Pure Global

Reich tissue transglutaminase immunoglobulin A antibody detection reagent - Taiwan Registration 09796029ec92072db99088a8184e5e81

Access comprehensive regulatory information for Reich tissue transglutaminase immunoglobulin A antibody detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 09796029ec92072db99088a8184e5e81 and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
09796029ec92072db99088a8184e5e81
Registration Details
Taiwan FDA Registration: 09796029ec92072db99088a8184e5e81
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Reich tissue transglutaminase immunoglobulin A antibody detection reagent
TW: ็ฆฎไบžๅฐš็ต„็น”่ฝ‰่ฐทๆฐจ้…ฐ่ƒบ้…ถๅ…็–ซ็ƒ่›‹็™ฝAๆŠ—้ซ”ๆชขๆธฌ่ฉฆๅŠ‘
Risk Class 2

Registration Details

09796029ec92072db99088a8184e5e81

DHA00602472000

Company Information

Italy

Product Details

Reich Transglutaminase Immunoglobulin A Antibody Assay is a quantitative determination of transglutaminase immunoglobulin A antibody content in human tissue in human serum or plasma using chemical cold light immunoassay (CLIA) technology. The concentration of immunoglobulin A antibodies in transglutaminase, along with other laboratory tests and clinical findings, may be useful in the diagnosis and monitoring of celiac disease (gluten-sensitive intestinal lesions). The experiment must be performed using a Reasan analyzer.

C Immunology and microbiology

C.5660 ๅคš็™ผๆ€ง่‡ช้ซ”ๆŠ—้ซ”ๅ…็–ซ่ฉฆ้ฉ—็ณป็ตฑ

import

Dates and Status

Jan 30, 2013

Jan 30, 2028